Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially

Alberto Palazzuoli1, Claudio Ronco

  • 1Department of Internal Medicine and Metabolic Diseases, Cardiology Section, University of Siena, Siena, Italy. palazzuoli2@unisi.it

Heart Failure Reviews
|August 9, 2011
PubMed

Insights

Cardio-renal syndromes link heart failure and chronic kidney disease, worsening patient outcomes. Understanding the "vicious heart/kidney circle" is key to reducing mortality and hospitalizations.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Heart failure (HF) and chronic kidney disease (CKD) are interconnected, contributing to cardio-renal syndromes.
  • Renal impairment in HF patients is an independent risk factor for morbidity and mortality, yet often excluded from clinical trials.
  • The mechanisms linking renal insufficiency to worse HF outcomes, forming a

Purpose of the Study:

  • To elucidate the mechanisms underlying the adverse outcomes in patients with cardio-renal syndromes.
  • To explore the

Main Methods:

  • Review of existing literature on cardio-renal syndromes.
  • Analysis of pathophysiological pathways linking renal and cardiac dysfunction.

Main Results:

  • Renal impairment exacerbates HF outcomes through complex mechanisms, not solely hypoperfusion.
  • Neurohormonal activation (sympathetic activity, renin-angiotensin-aldosterone, arginine-vasopressin) plays a crucial role.
  • These pathways lead to fluid retention, vasoconstriction, and increased cardiac workload.

Conclusions:

  • Targeting renal dysfunction, neurohormonal activation, and renal blood flow may improve outcomes in cardio-renal syndrome.
  • Interventions aimed at ameliorating renal function and reducing cardiac workload are crucial.
  • Further research is needed to fully understand and manage cardio-renal interactions.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...